Compared with the control group, the expression of CX3CL1 and the M1 macrophage marker (iNOS) were significantly increased in the intestinal tissue of AS patients with IBD (Fig. 2C–E). The gene discussed is CX3CL1; the disease is inflammatory bowel disease.